Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
In hyperandrogenic women, several phenotypes may be observed. This includes women with classic polycystic ovary syndrome (C-PCOS), those with ovulatory (OV) PCOS, and women with idiopathic hyperandrogenism (IHA), which occurs in women with normal ovaries. Where other causes have been excluded, we categorized 290 hyperandrogenic women who were seen consecutively for this complaint between 1993 and 2004 into these three subgroups. The aim was to compare the prevalence of obesity, insulin resistance, and dyslipidemia as well as increases in C-reactive protein and homocysteine in these different phenotypes with age-matched ovulatory controls of normal weight (n = 85) and others matched for body mass index (BMI) with women with C-PCOS (n = 42). Although BMI affected fasting serum insulin and the Quantitative Insulin-Sensitivity Check Index, these markers of insulin resistance were greatest in C-PCOS (n = 204), followed by OV-PCOS (n = 50) and then IHA (n = 33). Androgen levels were similar in OV-PCOS and IHA but were higher in C-PCOS, whereas gonadotropins were similar in all groups. Lipid abnormalities were highest in C-PCOS and OV-PCOS and were normal in IHA. C-reactive protein was elevated in C-PCOS and OV-PCOS but not IHA. Homocysteine was elevated only in C-PCOS. Overall, the prevalence of obesity (BMI > 30) was 29% in C-PCOS, 8% in OV-PCOS, and 15% in IHA and insulin resistance (Quantitative Insulin-Sensitivity Check Index < 0.33) was 68% in C-PCOS, 36% in OV-PCOS, and 26% in IHA. The prevalence of having at least one elevated cardiovascular risk marker was 45% in C-PCOS 38% in OV-PCOS and was not increased on IHA (6%). These results suggest that among hyperandrogenic women the prevalence of abnormal metabolic and cardiovascular risk parameters is greatest in C-PCOS, followed by OV-PCOS and then women with IHA. Moreover, in that in OV-PCOS and IHA, ages and weights were similar yet the prevalence of metabolic and cardiovascular risk was greater in OV-PCOS, the finding of polycystic ovaries may be a significant modifying factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 8×
“The following criteria were considered as being abnormal: obesity, BMI 30 or more; insulin resistance, QUICKI 0.330 or less (16); dyslipidemia, total cholesterol, 200 mg/dl or more and/or HDL-cholesterol, 40 mg/dl or less, and/or LDL-cholesterol, 130 mg/dl or more, and/or triglycerides, 150 mg/dl or more.”
MethodInfluentialMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · cited 1×
“It is interesting to note that, in our patients with C-PCOS, the HDL-cholesterol levels were higher and the triglyceride levels were lower than those reported in other studies of women with PCOS ( 19 ).”
ResultDepartment of Obstetrics and Gynecology
(2015) · Juntendo Medical Journal · doi:10.14789/jmj.61.322 · Cited by 365
Carmina, E., & Lobo, R. A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.01.041 · Cited by 294
Self-citationCarmina, E. (2003) · Human Reproduction · doi:10.1093/humrep/deg440 · Cited by 197
Self-citationAndrogen excess is the key element in polycystic ovary syndrome
Azziz, R. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00735-0 · Cited by 124
Prolactin modulation of dehydroepiandrosterone sulfate secretion
Lobo, R. A., Kletzky, O. A., Kaptein, E. M., & Goebelsmann, U. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90079-4 · Cited by 120
Prevalence of idiopathic hirsutism
Carmina, E. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390421 · Cited by 116
Self-citationDo hyperandrogenic women with normal menses have polycystic ovary syndrome?
Carmina, E., & Løbo, R. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00455-5 · Cited by 113
Self-citationPolycystic ovaries in hirsute women with normal menses
Carmina, E., & Løbo, R. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00979-2 · Cited by 101
Self-citationAssay Methods for the Measurement of Total Homocyst(e)ine in Plasma
Ubbink, J. (2000) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2000-8468 · Cited by 79
Measurement of C‐reactive protein: Two high sensitivity methods compared
Dominici, R., Luraschi, P., & Franzini, C. (2004) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20038 · Cited by 63
Carmina, E., Stanczyk, F. Z., & Løbo, R. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00034-2 · Cited by 59
Self-citationStanczyk, F. Z., Chang, L., Carmina, E., Putz, Z., & Løbo, R. A. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90042-p · Cited by 48
Self-citationComplex alternative splicing of the GH-V gene in the human testis
Untergasser, G., Hermann, M., Rumpold, H. F., et al. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390424 · Cited by 31
Polycystic Ovary Syndrome: Diagnostic Criteria
Chang, R. J. (2002) · CRC Press eBooks · doi:10.3109/9780203910948-28 · Cited by 27
Research works printed but not linked: 1
- Zawdaki, 1992, Diagnostic criteria for polycystic ovary syndrome: toward a rationale approach, In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377
Cited by
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citationAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“Contrast this with a recent multicenter trial at 22 sites in the United States in PCOS, where the BMI in the four treatment arms (total n ¼ 305) ranged from 35 to 38 kg/ m2 (219).”
BackgroundInfluentialSelf-citationAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Metadata
- Authors
- Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A.
- Affiliations
- University of Palermo (IT)
- Columbia University (US)
- Department of Obstetrics and Gynecology (M.C.C., R.A.Lob.), Columbia University, New York, New York 10032-3784
- ORCID
- Carmina, E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-05-01
- Volume
- 90
- Issue
- 5
- Pages
- 2545-2549
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2030643176
- Cited by
- 274
- References
- 21
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 1 · 2023: 10 · 2022: 10 · 2021: 9 · 2020: 2 · 2019: 8 · 2018: 6 · 2017: 10 · 2016: 16 · 2015: 11 · 2014: 15 · 2013: 15 · 2012: 16
- FWCI
- 27.36
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, hyperandrogenism, insulin resistance, obesity, dyslipidemia, cardiovascular risk factors, C-reactive protein, homocysteine, QUICKI, metabolic risk, phenotypic classification, androgen levels, gonadotropins, body mass index
- MeSH terms
- C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Insulin, Insulin Resistance, Luteinizing Hormone, Cholesterol, LDL, Phenotype, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.